EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Steris's enterprise value is $24,136 Mil.
Steris's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $1,359 Mil. Therefore, Steris's EV-to-EBITDA for today is 17.76.
The historical rank and industry rank for Steris's EV-to-EBITDA or its related term are showing as below:
STE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.22 Med: 18.85 Max: 38.41
Current: 17.76
During the past 13 years, the highest EV-to-EBITDA of Steris was 38.41. The lowest was 12.22. And the median was 18.85.
STE's EV-to-EBITDA is ranked worse than 54.84% of 496
companies
in the Medical Devices & Instruments industry
Industry Median: 15.85
vs STE: 17.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2025-07-18), Steris's stock price is $225.58.
Steris's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $6.200. Therefore, Steris's PE Ratio (TTM) for today is 36.38.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Steris EV-to-EBITDA Historical Data
The historical data trend for Steris's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Steris's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Steris's EV-to-EBITDA falls into.
Steris's current Enterprise Value is $24,136 Mil.
Steris's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,359 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris (NYSE:STE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Steris's share price for today is $225.58.
Steris's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.200.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Steris's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STE has been successfully added to your 